EV Insights: Voices from Exosomes Europe

Discover how Spencer Marsh, Chief Scientific Officer at The Tiny Cargo Company, is revolutionising drug delivery through milk-derived exosomes. In this exclusive interview, Spencer shares his journey from cardiac tissue research to developing shelf-stable, orally-administered therapeutics. Learn about the company's innovative approach to loading pharmaceuticals into milk exosomes, the challenges facing the EV industry, and why exosome therapies may soon replace traditional cell therapies. Don't miss Spencer's insights at Exosomes Europe 2025, where he'll discuss manufacturing innovations and the untapped potential of alternative exosome sources.